Reports
Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.
Global Immunotherapy Drugs Market: By Type: Monoclonal Antibodies, Vaccines, Interferons Alpha and Beta, Interleukins, Others; By Therapy Area: Cancer, Others; Regional Analysis; Historical Market and Forecast (2018-2028); Market Dynamics: SWOT Analysis; Value Chain Analysis; Competitive Landscape; Industry Events and Developments
Global Immunotherapy Drugs Market Outlook
The global immunotherapy drugs market attained a value of USD 179.6 billion in 2021. The market is further expected to grow in the forecast period of 2023-2028 at a CAGR of 11.20% to reach USD 339.6 billion by 2027.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Rising Incidences of Cancer to Propel the Growth of the Global Immunotherapy Drugs Industry
According to the WHO, cancer is the second leading cause of death globally, which led to nearly 10 million deaths in 2020. As a result, the governments and international organisations are increasingly conceptualising initiatives to generate funds while also spreading awareness about various types of cancer and the potential prevention strategies.
These factors are expected to drive the market growth in the coming years. Additionally, the increased expenditure in the healthcare sector and the accessibility to efficient therapeutic techniques, including target-specific and tailored treatments, are also projected to propel the global immunotherapy drugs industry further. Immunotherapy boosts the body’s natural defences to combat the disease by aiding the immune system to recognise and attack cancerous cells.
Geographically, North America is anticipated to account for a significant market share of the immunotherapy drugs industry. This can be attributed to the rising geriatric population in the region and the availability of improved medical facilities.
Immunotherapy Drugs: Market Segmentation
Immunotherapy is a type of biological therapy, which is used as a treatment for cancer and helps patients fight cancer by providing a boost to the immune system's natural defences to locate and attack cancer cells in the body. Some of the drugs used in immunotherapy are Ipilimumab (Yervoy®), Pembrolizumab (Keytruda®), Nivolumab (Opdivo®), and Atezolizumab (Tecentriq®), among others.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The major types of immunotherapy drugs are:
- Monoclonal Antibodies
- Vaccines
- Interferons Alpha and Beta
- Interleukins
- Others
The market can be broadly categorised, on the basis of therapy area, into:
- Cancer
- Autoimmune and Inflammatory Diseases
- Infectious Diseases
- Others
The EMR report looks into the regional markets of immunotherapy drugs like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Heightened Research and Development Activities to Augment the Growth of the Global Immunotherapy Drugs Industry
The immunotherapy drugs industry is anticipated to witness growth in both developed as well as developing nations. This can be associated with the rising geriatric population and increasing incidences of chronic illnesses worldwide. Additionally, the increasing expenditure by the leading pharmaceutical companies in the research and development of efficient immunotherapy medications is estimated to propel the industry growth. Furthermore, the growing investments by the governments in the development of healthcare infrastructure are further projected to positively stimulate the market growth in the coming years. Moreover, the market is further expected to be fuelled by the rapid technological advancements in the pharmaceutical industry.
Key Industry Players in the Global Immunotherapy Drugs Market
The report presents a detailed analysis of the following key players in the global immunotherapy drugs market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- AbbVie Inc.
- Amgen Inc.
- AstraZeneca PLC
- GlaxoSmithKline PLC
- F. Hoffmann-La Roche AG
- Others
The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2022 |
| Historical Period | 2018-2022 |
| Forecast Period | 2023-2028 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Type, Therapy Area, Region |
| Breakup by Type | Monoclonal Antibodies, Vaccines, Interferons Alpha and Beta, Interleukins, Others |
| Breakup by Therapy Area | Cancer, Autoimmune and Inflammatory Diseases, Infectious Diseases, Others |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | AbbVie Inc., Amgen Inc., AstraZeneca PLC, GlaxoSmithKline PLC, F. Hoffmann-La Roche AG, Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Immunotherapy Drugs Market Analysis
8.1 Key Industry Highlights
8.2 Global Immunotherapy Drugs Historical Market (2018-2022)
8.3 Global Immunotherapy Drugs Market Forecast (2023-2028)
8.4 Global Immunotherapy Drugs Market by Type
8.4.1 Monoclonal Antibodies
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2022)
8.4.1.3 Forecast Trend (2023-2028)
8.4.2 Vaccines
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2022)
8.4.2.3 Forecast Trend (2023-2028)
8.4.3 Interferons Alpha and Beta
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2018-2022)
8.4.3.3 Forecast Trend (2023-2028)
8.4.4 Interleukins
8.4.4.1 Market Share
8.4.4.2 Historical Trend (2018-2022)
8.4.4.3 Forecast Trend (2023-2028)
8.4.5 Others
8.5 Global Immunotherapy Drugs Market by Therapy Area
8.5.1 Cancer
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2018-2022)
8.5.1.3 Forecast Trend (2023-2028)
8.5.2 Autoimmune and Inflammatory Diseases
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2018-2022)
8.5.2.3 Forecast Trend (2023-2028)
8.5.3 Infectious Diseases
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2018-2022)
8.5.3.3 Forecast Trend (2023-2028)
8.5.4 Others
8.6 Global Immunotherapy Drugs Market by Region
8.6.1 Market Share
8.6.1.1 North America
8.6.1.2 Europe
8.6.1.3 Asia Pacific
8.6.1.4 Latin America
8.6.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2018-2022)
9.1.2 Forecast Trend (2023-2028)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2018-2022)
9.2.2 Forecast Trend (2023-2028)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2018-2022)
9.3.2 Forecast Trend (2023-2028)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2018-2022)
9.4.2 Forecast Trend (2023-2028)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2018-2022)
9.5.2 Forecast Trend (2023-2028)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles
12.2.1 AbbVie Inc.
12.2.1.1 Company Overview
12.2.1.2 Product Portfolio
12.2.1.3 Demographic Reach and Achievements
12.2.1.4 Certifications
12.2.2 Amgen Inc.
12.2.2.1 Company Overview
12.2.2.2 Product Portfolio
12.2.2.3 Demographic Reach and Achievements
12.2.2.4 Certifications
12.2.3 AstraZeneca PLC
12.2.3.1 Company Overview
12.2.3.2 Product Portfolio
12.2.3.3 Demographic Reach and Achievements
12.2.3.4 Certifications
12.2.4 GlaxoSmithKline PLC
12.2.4.1 Company Overview
12.2.4.2 Product Portfolio
12.2.4.3 Demographic Reach and Achievements
12.2.4.4 Certifications
12.2.5 F. Hoffmann-La Roche AG
12.2.5.1 Company Overview
12.2.5.2 Product Portfolio
12.2.5.3 Demographic Reach and Achievements
12.2.5.4 Certifications
12.2.6 Others
13 Industry Events and Developments
List of Key Figures and Tables
1. Global Immunotherapy Drugs Market: Key Industry Highlights, 2018 and 2028
2. Global Immunotherapy Drugs Historical Market: Breakup by Type (USD Billion), 2018-2022
3. Global Immunotherapy Drugs Market Forecast: Breakup by Type (USD Billion), 2023-2028
4. Global Immunotherapy Drugs Historical Market: Breakup by Therapy Area (USD Billion), 2018-2022
5. Global Immunotherapy Drugs Market Forecast: Breakup by Therapy Area (USD Billion), 2023-2028
6. Global Immunotherapy Drugs Historical Market: Breakup by Region (USD Billion), 2018-2022
7. Global Immunotherapy Drugs Market Forecast: Breakup by Region (USD Billion), 2023-2028
8. North America Immunotherapy Drugs Historical Market: Breakup by Country (USD Billion), 2018-2022
9. North America Immunotherapy Drugs Market Forecast: Breakup by Country (USD Billion), 2023-2028
10. Europe Immunotherapy Drugs Historical Market: Breakup by Country (USD Billion), 2018-2022
11. Europe Immunotherapy Drugs Market Forecast: Breakup by Country (USD Billion), 2023-2028
12. Asia Pacific Immunotherapy Drugs Historical Market: Breakup by Country (USD Billion), 2018-2022
13. Asia Pacific Immunotherapy Drugs Market Forecast: Breakup by Country (USD Billion), 2023-2028
14. Latin America Immunotherapy Drugs Historical Market: Breakup by Country (USD Billion), 2018-2022
15. Latin America Immunotherapy Drugs Market Forecast: Breakup by Country (USD Billion), 2023-2028
16. Middle East and Africa Immunotherapy Drugs Historical Market: Breakup by Country (USD Billion), 2018-2022
17. Middle East and Africa Immunotherapy Drugs Market Forecast: Breakup by Country (USD Billion), 2023-2028
18. Global Immunotherapy Drugs Market Structure
Key Questions Answered in the Report
In 2021, the global immunotherapy drugs market attained a value of nearly USD 179.6 billion.
The market is projected to grow at a CAGR of 11.20% between 2023 and 2028.
The market is estimated to witness a healthy growth in the forecast period of 2023-2028 to reach USD 339.6 billion by 2027.
The major drivers of the industry, such as the rising expenditure in the healthcare industry, rising consciousness pertaining to the availability of cancer treatments, increasing research and development activities, and rapidly growing geriatric global population, are expected to aid the market growth.
The key market trends guiding the growth of the industry include the increased prevalence of cancer cases worldwide.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The significant types of immunotherapy drugs in the industry are monoclonal antibodies, vaccines, interferons alpha and beta, and interleukins, among others.
The significant market divisions, based on therapy areas, include cancer, autoimmune and inflammatory diseases, and infectious diseases, among others.
The major players in the industry are AbbVie Inc., Amgen Inc., AstraZeneca PLC, GlaxoSmithKline PLC, and F. Hoffmann-La Roche AG, among others.
Analyst Review
The global immunotherapy drugs market attained a value of nearly USD 179.6 billion in 2021, driven by the rising prevalence of cancer and other chronic illnesses worldwide. Aided by the growing investments in the pharmaceutical industry, the market is expected to witness a further growth in the forecast period of 2023-2028, growing at a CAGR of 11.20%. The market is projected to reach USD 339.6 billion by 2027.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on type, the immunotherapy drugs industry can be segmented into monoclonal antibodies, vaccines, interferons alpha and beta, and interleukins, among others. On the basis of therapy area, the industry can be classified into cancer, autoimmune and inflammatory diseases, and infectious diseases, among others. The major regional markets for immunotherapy drugs are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include AbbVie Inc., Amgen Inc., AstraZeneca PLC, GlaxoSmithKline PLC, and F. Hoffmann-La Roche AG, among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2699-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
$3699-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4699-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
NEWSLETTER